Advertisement
Research Article| Volume 12, ISSUE 4, P655-667, December 1992

Evolution in Indications for Blood Component Transfusion

DOI:https://doi.org/10.1016/S0272-2712(18)30479-7
Evolution in Indications for Blood Component Transfusion
Previous ArticlePreface
Next ArticleDonor Screening
      This paper is only available as a PDF. To read, Please Download here.
      The indications for blood component transfusion continue to evolve. The suggested hemoglobin level for red cell transfusion has been lowered from 10 to 7 g/dL with indices of oxygen delivery and consumption promoted for clinical decision making. More conservative criteria for platelet transfusion have been supported by new data, with levels of 5000/mm3 for the bleeding patient. Plasma and cryoprecipitate transfusion are based on the laboratory assays for coagulation combined with clinical bleeding or the requirement for an invasive procedure. Guidelines based on consensus are available but cannot replace careful correlation of clinical and laboratory assessment of the patient.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Alverson D.C.
        • Isken V.H.
        • Cohen R.S.
        Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia.
        J Pediatr. 1988; 113: 712
        • Andrew M.
        Platelets in newborns: Physiology and pathology.
        Transfus Sci. 1991; 12: 207
        • Braunstein A.H.
        • Oberman H.A.
        Transfusion of plasma components.
        Transfusion. 1984; 24: 281
        • Bray G.L.
        Normal and disordered coagulation in the neonate.
        Transfus Sci. 1991; 12: 231
        • Counts R.B.
        • Haisch C.
        • Simon T.L.
        • et al.
        Hemostasis in massively transfused trauma patients.
        Ann Surg. 1979; 190: 91
        • Crowley J.P.
        Transfusion of plasma.
        in: Rossi E.C. Simon T.L. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 335
        • Erslev A.J.
        Clinical manifestations and classification of erythocyte disorders.
        in: Williams W.J. Beutler E. Erslev A.J. Hematology. McGraw-Hill, New York1990: 423
        • Gaydos L.A.
        • Freireich E.F.
        • Mantel N.
        The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.
        N Engl J Med. 1962; 266: 905
        • Gmur J.
        • Burger J.
        • Schanzu
        • et al.
        Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia.
        Lancet. 1991; 338: 1223
        • Goodnough L.T.
        • Johnston M.F.M.
        • Ramsey G.
        • et al.
        Guidelines for transfusion support in patients undergoing coronary artery bypass grafting.
        Ann Thorac Surg. 1990; 50: 675
        • Gould S.A.
        • Moss G.S.
        Administration of red cells: The transfusion trigger and red cell substitutes.
        in: Rossi E. Simon T. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 345
        • Heyman M.R.
        • Schiffer C.A.
        Platelet transfusion to patients receiving chemotherapy.
        in: Rossi E. Simon T. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 223
        • Leslie S.D.
        • Toy P.T.C.Y.
        Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid.
        Am J Clin Pathol. 1991; 96: 770
        • Office of Medical Application of Research, National Institutes of Health
        Fresh frozen plasma: Indications and risks.
        JAMA. 1985; 253: 551
        • Office of Medical Application of Research, National Institutes of Health
        Perioperative red cell transfusion.
        JAMA. 1988; 260: 2700
        • Office of Medical Application of Research, National Institutes of Health
        Platelet transfusions.
        JAMA. 1987; 257: 1777
        • Reed R.
        • Ciavarella D.
        • Heimback D.
        • et al.
        Prophylactic platelet administration during massive transfusion.
        Ann Surg. 1986; 203: 40
        • Simon T.L.
        Platelet consumption and dysfunction.
        in: Rossi E.C. Simon T.L. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 265
        • Simon T.L.
        • Akl B.
        • Murphy W.
        Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery.
        Ann Thorac Surg. 1984; 37: 359
        • Slichter S.J.
        Controversies in platelet transfusion therapy.
        Ann Rev Med. 1980; 31: 509
        • van Aken W.G.
        Preparation of plasma derivatives.
        in: Rossi E.C. Simon T.L. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 323
        • Wardrop C.A.J.
        • Jones J.G.
        • Holland B.M.
        Detection, correction and ultimate prevention of anemias in the preterm infant.
        Transfus Sci. 1991; 12: 257
        • Warkentin T.E.
        • Kelton J.G.
        Immune thrombocytopenia and its management.
        in: Rossi E.C. Simon T.L. Moss G.S. Principles of Transfusion Medicine. Williams and Wilkins, Baltimore1991: 233
        • Zauder H.L.
        Preoperative hemoglobin requirements.
        Anesthesiol Clin North Am. 1990; 8: 471

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30479-7

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX